Allan Reine

52 posts

Allan Reine banner
Allan Reine

Allan Reine

@Allan_Reine

CEO @PrimeMedicine | Pioneering Prime Editing to cure genetic diseases | MD | 25+ years in biotech | Turning science into life-changing therapies 🧬

New York Katılım Haziran 2009
579 Takip Edilen415 Takipçiler
Allan Reine
Allan Reine@Allan_Reine·
Excited to welcome Svetlana Makhni as CFO of Prime Medicine. Svetlana brings deep biotech and financial leadership experience as we continue advancing Prime Editing and our mission for patients. Welcome to Prime!
Prime Medicine@PrimeMedicine

We’re excited to welcome Svetlana Makhni as Chief Financial Officer of Prime Medicine. Svetlana brings extensive experience across biotech finance, corporate development, & investor engagement as we continue advancing Prime Editing. #PrimeMedicine #BiotechLeadership #PrimeEditing

English
0
0
11
698
Allan Reine retweetledi
Prime Medicine
Prime Medicine@PrimeMedicine·
CEO Allan Reine joined the Citizens Life Sciences and Jefferies conferences this week, including a fireside chat with Silvan Türkcan. Great opportunity to connect with the life sciences and investor community and share updates on the progress being driven across the team at Prime
Prime Medicine tweet media
English
1
6
24
1.2K
Allan Reine retweetledi
Prime Medicine
Prime Medicine@PrimeMedicine·
Today we celebrate the women at Prime Medicine and across science and medicine, who drive innovation, collaboration, and progress every day. Thank you for pushing boundaries and shaping the future of gene editing. Happy International Women’s Day. #IWD2026 #WomenInScience
English
0
1
16
776
Allan Reine retweetledi
Prime Medicine
Prime Medicine@PrimeMedicine·
Last week, our team attended the @CF_Foundation 70th Annual Dinner, an inspiring evening honoring the CF community and the work driving progress forward. Proud to support and stand alongside this mission. #CysticFibrosis #CFAdvocay
Prime Medicine tweet media
English
1
4
33
1.8K
Allan Reine
Allan Reine@Allan_Reine·
Proud to share today’s update from the Prime Medicine team. This past year reflects the hard work and dedication behind advancing Prime Editing and moving our mission forward for patients. Grateful to everyone at Prime pushing the science and the vision every day. #PrimeMedicine #PrimeEditing #Leadership
Prime Medicine@PrimeMedicine

Today, we’ve shared our full‑year 2025 financial results and business update. This past year brought important progress across our Prime Editing platform. Full release: investors.primemedicine.com/news-releases/… #PrimeMedicine #Biotech #PrimeEditing

English
4
2
30
3.1K
Allan Reine
Allan Reine@Allan_Reine·
Innovation begins with imagination. The latest work from @CIHR_IRSC is a powerful reminder of what’s possible when we dare to push science forward. At Prime Medicine, we’re inspired every day to help build a future where groundbreaking research transforms lives. Read more: cihr-irsc.gc.ca/e/54638.html
English
0
1
11
1.4K
Allan Reine retweetledi
David R. Liu
David R. Liu@davidrliu·
Below is the story of the first patient treated with a prime-edited therapeutic, developed by @PrimeMedicine in a trial led by Dr. Élie Haddad and his team at CHU Sainte-Justine. This teenager suffered from chronic granulomatous disease (CGD), an immunodeficiency, and now—10 months after treatment—the patient is healthy, stable, and living with a functioning immune system. Tracy Attebury, whose story was previously told by @ginakolata @nytimes, was the second patient treated with a prime-edited therapeutic. cihr-irsc.gc.ca/e/54638.html
David R. Liu tweet media
English
29
167
891
173.7K
Allan Reine
Allan Reine@Allan_Reine·
Big congratulations to @davidrliu on his recognition in @TheWashingtonPost Next50. His vision fuels our mission at Prime Medicine to deliver precise, one‑time curative genetic therapies through Prime Editing. Excited for the future!
David R. Liu@davidrliu

I'm honored to be included in the @washingtonpost Next 50, representing a remarkable community—scientists, physicians, caregivers, and the patients who inspire us—working together to bring the life-saving promise of therapeutic gene editing to those living with genetic diseases. Profile by Carolyn Johnson: drive.google.com/file/d/1GJYKnZ… washingtonpost.com/post-next/inte…

English
0
1
20
1.2K
Allan Reine retweetledi
David R. Liu
David R. Liu@davidrliu·
Today in @Nature we report a new prime editing strategy that can rescue a common cause of many genetic diseases in a disease-agnostic manner. This approach converts a redundant endogenous tRNA into an optimized suppressor tRNA, enabling a single prime edit to rescue premature stop codons across different diseases. (1/15) drive.google.com/file/d/1bSvkJW…
David R. Liu tweet media
English
40
398
1.4K
250.7K
Allan Reine retweetledi
60 Minutes
60 Minutes@60Minutes·
Harvard chemist and molecular biologist David Liu invented gene editing tools that can correct and rewrite defective genes. His research could one day help hundreds of millions of people with genetic diseases, including sickle cell and muscular dystrophy. cbsn.ws/4oyLApL
English
196
779
2.9K
251.4K
Allan Reine retweetledi
David R. Liu
David R. Liu@davidrliu·
Today in @CellCellPress we report the use of prime editing to correct several mutations that cause alternating hemiplegia of childhood (AHC), a rare and devastating neurodevelopmental disorder, in patient-derived cells and in two mouse models. drive.google.com/file/d/1ibC50t… 1/10
David R. Liu tweet media
English
15
134
678
77K
Allan Reine retweetledi
David R. Liu
David R. Liu@davidrliu·
Another medical milestone! The first patient treated with a prime edited therapeutic shows positive clinical outcomes consistent with effective rescue of his chronic granulomatous disease (CGD), a debilitating and life-shortening primary immunodeficiency. At least 19 base editing and prime editing clinical trials have begun, with at least 7 trials reporting clinical outcomes (highlighted in green in the table below). They treat a wide range of diseases both in vivo and ex vivo. And while the U.S. support for science is now in crisis, that there are more base editing and prime editing clinical trials serving patients outside of the U.S. (13) than within the U.S. (9), despite the fact that these technologies were developed in our lab in the U.S. investors.primemedicine.com/news-releases/…
David R. Liu tweet mediaDavid R. Liu tweet mediaDavid R. Liu tweet mediaDavid R. Liu tweet media
English
18
168
795
69.2K
Allan Reine retweetledi
Endpoints News
Endpoints News@endpts·
Eli Lilly's Jake Van Naarden uncorked a deal to provide Flagship-backed Foghorn Therapeutics $380 million — $300 million in cash and $80 million for a premium equity deal — to jump on board the biotech’s development platform. endpts.com/eli-lillys-van…
English
0
7
21
0
Allan Reine retweetledi
Foghorn Therapeutics
Foghorn Therapeutics@foghorntx·
We are delighted to announce a strategic collaboration with @Merck to discover and develop novel oncology therapeutics against a transcription factor target relevant to a broad range of #cancer patients. Learn more: bit.ly/38AGiUm
Foghorn Therapeutics tweet media
English
0
2
16
0
Allan Reine retweetledi
Foghorn Therapeutics
Foghorn Therapeutics@foghorntx·
We had a groundbreaking party to celebrate the start of renovating our #newHQ. Thanks to Alexandria Real Estate Equities, @CBRE, @WiseBuilds and @Tria_Inc for making this project possible! Check back for updates as the renovation continues. #FogFam
Foghorn Therapeutics tweet media
English
0
2
15
0
Allan Reine retweetledi
Foghorn Therapeutics
Foghorn Therapeutics@foghorntx·
At #JPM20, our president and CEO Adrian Gottschalk presented about our recent progress on advancing an entirely new class of medicines targeting the #chromatin regulatory system.
Foghorn Therapeutics tweet media
English
0
4
10
0